It is generally known that blue color beautifies the look, instills confidence and signifies sex appeal, but who would say that the same blue color also has medicinal properties. That! Blue scorpions have just this trait. Rhopalurus junceus, the venom of the blue scorpion, patented in Cuba, has anti-cancer and analgesic properties. As a homeopathic remedy, this medicinal poison is called Vidatox .

Scorpions have a venomous sting at the end of their tail that is not only used for defense, scorpions also use it to paralyze their prey.

The belief that scorpion venom can be used for therapeutic purposes has been present for thousands of years, and its use for these purposes has been documented in many writings of traditional medicine and also in oral traditions.

Scorpion venom

scorpion venom cancer

The toxins in the poison are actually proteins and peptites which are found in the venom of scorpions and their task at the molecular level is to interfere with ion channels. The toxin integrates into sodium channels and makes communication between neurons difficult.

Using poison scorpion

Scorpion venom contains a wide range of numerous bioactive compounds that possess some useful properties. This venom comprises several peptides of lower molecular weight. This poison has extensive pharmacological activities, which include the fight against malignant diseases.

Blue scorpion venom and its use in the treatment of cancer

Rhopalurus junceus (blue scorpion venom) has been shown to have anti-cancer effects.  The active compounds that have anticancer activity are Escosine and Escosul, Chlorotoxin and 36 other amino acid peptides derived from scorpion venom.

Chlorotoxin has a tendency to attach to glioma cells (a type of tumor that occurs in the brain and spinal cord), which has enabled the further development of new techniques for the control and identification of numerous types of malignancies.

Dr. Mikaelian and Ecosin

escozine production

Russian emigrant Dr. Arthur Mikaelian and his corporation Medolaif, have created a recipe known as Escozin, which is actually one of the active substances in the venom of the blue scorpion. Dr. Arthur and his colleague Sebastian Serel Watts recognized the miraculous powers of Escorzin. In addition to hitting malignant cells, scorpion venom can fight against autoimmune diseases, HIV, hepatitis and also against male impotence.

When asked why large pharmacological corporations (which spend billions of dollars on research into drugs for malignancy) did not promote scorpion venom as a drug, Dr. Mikaelian stated that pharmacological corporations cannot register a biological product and claim copyright.

Medolaif Corporation has a farm with a large number of scorpions in the Dominican Republic. Scorpion venom was obtained by squeezing from a sting, and they specialized in a laboratory in Santo Domingo. From one scorpion, 5 to 7 drops can be obtained in one month, and a very small amount is implemented in small bottles that are sold at a very high price. The amount in the bottle is enough for about 30 days of use.

Medolaif Corporation states that Ecosine is used for the use and treatment of cancer patients. According to Watts, the same drug was registered in Russia, Belarus, Kazakhstan and Vietnam under the name Vidatoc. Ecosin and Vidatox have a 90% success rate in improving the quality of life of people with cancer, reducing pain and increasing the possibility of cure.

A step forward in research, paint for tumors

cancer staining

The FDA has approved the research of anti-malignant drugs called tumor dyes (prepared from scorpion venom) for 21 patients (who suffered from brain malignancies).  This compound literally stained the malignant parts of the brain as it becomes visible under certain types of light during the patient’s surgery.

The girl  at the age of 17 she underwent a ten-hour operation that required the removal of a malignant brain tumor. Despite the very work done, the surgeons were not able to eliminate all the cancer-affected tissue because certain parts were hidden behind perfectly normal tissue. Pediatric oncologist Dr. Olson and his team found that the chlorotoxin present in scorpion venom could bind to malignant tissue and mark it under special light during surgery. In this way, the problem of removing your unhealthy tissue during the operation and its precise removal from the body is solved.

Tumor dye has now been tested on human beings and the statistics of successful operations have drastically increased with this discovery. This is one of the revolutionary reforms in the treatment of malignancy.

Results others studies

Research conducted on Colima University (Southwest Mexico) have identified a carefully selected group of peptides (scorpion venom Centruroides tecomanus) that had anti-cancer properties. When the venom attacks malignant cells, it promotes apoptosis which leads to the death of cancer cells

The story of Peggy Howe

Baki from Kansas, Peggy Howe, was diagnosed with grade 4 breast cancer in 2011.  Although she underwent chemotherapy and radiation, her grandmother’s malignancy spread to her liver and lungs. As the disease progressed tremendously, Peggy began taking Escozin as a last resort to save her life. Within 24 hours, she felt an influx of energy in the body and after that, in a period of 6 months, the blinking disappeared. Peggy was so happy that she did a scorpion tattoo on her wrist.

Programmed apoptosis cell death

The toxins Tuyus discrepans, Andoctonus crassicauda, and Odontobuhus doriae scorpion are used as activators of programmed death of breast cancer cells. Two unique peptides naopladin 1 and nepoladin 2 were filtered from the scorpion venom of Tityus discrepans and were found to be very effective against human breast cancer type SKBR3.  BmKAEP is a neurotoxin from the venom of the Manchurian scorpion Mesobuthus martensii. It is a beta toxin, which modifies the level of electricity in the sodium pathways.

The same neurotoxin interferes with the spread of leukemia by increasing the development and formation of red blood cells and reducing the number of malignant cells.